Definitive Contract HHSN268201700003C
Award Date
11/15/16
Potential Completion Date
8/14/19
Potential Value
$783K
Federal Agency
National Heart Lung and Blood Institute
Awardee
Sujana Biotech, LLC
Ultimate Awardee
Not listed
NAICS Category
541712 - Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Beachwood, OH 44122, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
23
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract was awarded by the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency, to Dupage Medical Technology Inc., a minority-owned, for-profit organization, for the development of an inhibitor of integrin outside-in signaling as a new generation of anti-thrombotic drug. The definitive, cost-plus-fixed-fee contract has a ceiling value of $1,958,172.98 and a completion date of February 14, 2020. The contract was awarded on November 15, 2016 and does not have a...
This is a $97,680 firm fixed price contract awarded by the National Heart Lung and Blood Institute, a civilian agency within the U.S. Department of Health and Human Services. The contract was set aside for small businesses and awarded to Mediomics LLC, a woman-owned small business. The contract is for the development of APTAMER-BASED PINCERS FOR CARDIOVASCULAR BIOMARKERS, which aligns with the National Heart Lung and Blood Institute's mission to support research on heart, lung, and blood...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency of the U.S. government. The contract, valued at $224,944.00, was awarded to Sibtech, Inc. on September 8, 2014 and has a completion date of December 7, 2015. The contract aims to develop specific molecular imaging agents that can be used in combination with existing imaging modalities to detect high-risk atherosclerotic plaque. This research...
This federal contract award, valued at $76,361.60, was issued by the National Heart Lung and Blood Institute (NHLBI), a civilian agency within the U.S. Department of Health and Human Services. The award is a Delivery Order placed under the Multiple Award Schedule (MAS) contract vehicle. The contract was awarded to Government Scientific Source Inc., a for-profit small business organization, to provide a single-cell multiome reagent bundle, single-cell 3' kit V3.1, Chip G kit, Chip J kit, single...
<p>This is a federal contract award from the National Heart Lung and Blood Institute, a civilian agency, to Biomedomics, Inc., a minority-owned, for-profit manufacturer of goods, for a Small Business Innovation Research (SBIR) Program Phase I research project. The contract has a Firm Fixed Price of $99,932.00 and was awarded on December 1, 2009 with a completion date of May 31, 2010. The contract is set aside for small businesses. No additional subcontractors or context are provided.</p>
This is a $14,988.32 firm fixed price purchase order contract awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency under the U.S. Department of Health and Human Services. The contract was set aside for a small business and awarded to Yoon, Justine S., a woman-owned small business. The contract has an ultimate completion date of October 4, 2013 and was awarded on December 18, 2012. The contract's purpose is not specified in the information provided, but the NHLBI is...
This federal contract award, valued at $26,886.24, was issued by the National Heart, Lung, and Blood Institute (NHLBI), which is part of the National Institutes of Health (NIH), a civilian agency. The contract is a delivery order under the Solutions for Enterprise-Wide Procurement V (SEWP V) government-wide acquisition contract. The purpose of the award is to renew 250 BioRender institutional 12-month unlimited licenses for NHLBI ITAC researchers to create drawings for scientific publications...
The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a $1,100,000.00 firm-fixed-price purchase order contract to Transmural Systems LLC, a woman-owned small business, for the manufacture of 200 Active Guidewires for MRI-guided cardiovascular catheterization. This contract is part of the National Heart, Lung, and Blood Institute's Division of Intramural Research's efforts to develop radiation-free heart catheterization...
<p>This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency, to Nanoshell Company, LLC, a woman-owned small business. The contract, valued at $148,235.00, is for research into using haptoglobin as a treatment to reduce complications of sickle cell disease. The contract has a firm-fixed price and was awarded on August 1, 2012, with a target completion date of March 15, 2013.</p>
<p>The National Heart Lung and Blood Institute (NHLBI), a civilian agency, awarded a $75,000 firm fixed price purchase order contract to Objective Biotechnology, Inc., a minority-owned for-profit business, to provide a computer vision guided automated microinjection robot. The contract was awarded on September 11, 2024 and has an ultimate completion date of September 10, 2025. This award does not have a set-aside designation.</p>